TransNusa Expands Regional Network With Launch of Jakarta-Penang Route
PLN Strengthens Its Pathway to the Global Carbon Market Through Energy Transition Investments
IMPC Commits Rp250 billion (USD 15 million) to Build ASEAN’s Leading Polymer Training Center, Partnering with SKZ-German Plastics Center
Bitzero Holdings Inc. Announces Commencement of Trading on Canadian Securities Exchange
OTTICA By Optimax Eyewear Launches New Online Platform for Luxury Eyewear Shopping
Not for distribution to United States newswire services or dissemination in the Unites States SUDBURY,…
Ms. Micallef joins previous executive appointees from companies such as Amazon, Four Seasons, American Airlines,…
NIAGARA FALLS, ON / ACCESSWIRE / November 15, 2021 / EnerDynamic Hybrid Technologies Corp. (TSXV:EHT)…
ATLANTA, GA / ACCESSWIRE / November 15, 2021 / Trust Stamp (OTCQX:IDAI, Euronext Growth: AIID…
New University to Offer Online Master’s Degrees in Cutting-Edge Technology Fields Contemporary Technology University won’t…
SURREY, BC / ACCESSWIRE / November 15, 2021 / Condor Gold (AIM:CNR)(TSX:COG) announces that it…
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS,…
STOCKHOLM, SE / ACCESSWIRE / November 15, 2021 / Adverty AB (STO:ADVT) Adverty AB (publ)…
UK, Reading. November 15, 2021 – IGEL, provider of the next gen edge OS for…
BERKELEY, Calif. and MAINZ, Germany, Nov. 15, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ)…
Glycotope Presents New Data on Carbohydrate-Dependent Antibodies and Fusion-Proteins at the 2021 Society for Immunotherapy…
PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation…
Data presented at the 36th Annual Society for Immunotherapy of Cancer (SITC) Meeting NANTES, France,…
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting Cambridge,…
Geneva, Switzerland, November 15, 2021Â – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company…
Setting Up Global Expansion of Phase 2 Clinical Evaluation in Epilepsy Patients Ad Hoc Announcement…
PDUFA date set on 30 June 2022, ahead of the August to September 2022 timeframe…
THR-149 is a potent plasma kallikrein inhibitor for the treatment of DME in the roughly…
The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy…
Trial Results Highlighted Reduction in Cardiovascular Mortality, Heart Attacks and Strokes, with Greatest Effect Seen…